China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the mechanism of injectable hydrogel loaded with epimedium-derived extracellular vesicles to improve knee osteoarthritis by regulating chondrocyte ferroptosis through Nrf2/HO-1/GPX4 signaling axis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130550
Registration Time: 2026/08/21
Type: Observational study
Primary Sponsor: Foshan Hospital of Traditional Chinese Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338894
Published by HT Digital Content Services with permission from Health Daily Digest....